HYCOR BIOMEDICAL INC /DE/ 5/A
5/A · HYCOR BIOMEDICAL INC /DE/ · Filed Jan 14, 2004
Insider Transaction Report
Form 5/AAmended
DAVOUDZADEH DAVID PHD
Vice President, R&D
Transactions
- Exercise/Conversion
Common Stock
2003-12-31$3.31/sh+1,383$4,578→ 7,050 total - Exercise/Conversion
Common Stock
2003-06-30$1.78/sh+2,571$4,576→ 4,738 total - Exercise/Conversion
Common Stock
2003-09-30$4.22/sh+929$3,920→ 5,667 total